Amarin Corp Plc (AMRN)

[KCSVEN]

This study is pretty flawed.
has been discussed on other boards but they admit its an observational study, only used 4 communities, did not use people that had potential for heart issues. Is nowhere near a study that could be considered FDA approved.
They say straight out "this is an observational study--it doesn't prove cause and effect"
It does seem to lead you to the face REDUCE IT will likely be successful, just seems to indicate DHA+EPA might be more beneficial though other, better studies do not indicate that to be true

Also they state:
Temporal changes in fatty acid levels and misclassification of causes of death may have resulted in underestimated associations, and unmeasured or imperfectly measured covariates may have caused residual confounding.
And
2692 U.S. adults aged 74 years (±5 years) without prevalent coronary heart disease (CHD), stroke, or heart failure at baseline.

So, it's a pretty flawed study that they admit is
1) Not a study
2) May not be accurately tallied
3) All versions of fish oil help
4)DHA benefits all seem to be mainly from 1 category of risk reduction
5) Tries to adjust for adjusted for age, sex, race, education, enrollment site, fatty-acid-measurement batch (1994–1996 or 2007–2010), smoking status, diabetes, atrial fibrillation, drug-treated hypertension, physical activity, body-mass index, waist circumference, alcohol use, and consumption of tuna or other broiled or baked fish, fried fish, red meat, fruits, vegetables, and dietary fiber over many years with poorly designed controls which could easily skew data

I do not find much medical merit in this at all even though it does indicate REDUCE IT will be successful and even though it says DHA is better than EPA.